ASND

Ascendis Pharma A Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Ascendis Pharma A sales and earnings growth
ASND Growth
Good
  • Revenue Y/Y↑ 98.03%
  • EPS Y/Y↑ 42.42%
  • FCF Y/Y↑ 114.81%
Ascendis Pharma A gross and profit margin trends
ASND Profitability
Neutral
  • Gross margin ↑ 86.80%
  • EPS margin↓ -31.70%
  • ROIC 5Y↓ -44.36%
Ascendis Pharma A net debt vs free cash flow
ASND Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↑ 11.3
  • Interest coverage↓ 0.0

Ascendis Pharma A stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Biotechnology stocks ↗